EYEG EyeGate Pharmaceuticals, Inc.

NASDAQ
$33.87

EyeGate Pharmaceuticals, Inc. (EYEG) is expected to report earnings on March 24, 2022, before the market open.

Earnings Date
Mar 24
Thursday · Before Open
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc. is a pharmaceutical company which is engaged in developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye. The company's technology consists of EyeGate(R) II Delivery System. Its product pipeline includes EGP-437 which is in different clinical stage. EyeGate Pharmaceuticals, Inc. is based in WALTHAM, MA.

Charts powered in part by Lightweight Charts™ by TradingView.